HYALURONIDASE-OCSQ\OCRELIZUMAB for Relapsing multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where HYALURONIDASE-OCSQ\OCRELIZUMAB was used for Relapsing multiple sclerosis.
Most Reported Side Effects for HYALURONIDASE-OCSQ\OCRELIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site erythema | 23 | 13.5% | 0 | 2 |
| Off label use | 21 | 12.3% | 0 | 1 |
| Injection site pain | 20 | 11.7% | 0 | 2 |
| Contusion | 17 | 9.9% | 0 | 1 |
| Fatigue | 17 | 9.9% | 0 | 0 |
| No adverse event | 13 | 7.6% | 0 | 0 |
| Pain | 13 | 7.6% | 0 | 0 |
| Erythema | 12 | 7.0% | 0 | 0 |
| Injection site reaction | 12 | 7.0% | 0 | 0 |
| Headache | 10 | 5.9% | 0 | 0 |
| Injection site swelling | 10 | 5.9% | 0 | 2 |
| Rash | 10 | 5.9% | 0 | 0 |
| Swelling | 8 | 4.7% | 0 | 0 |
| Pain in extremity | 7 | 4.1% | 0 | 0 |
| Multiple sclerosis relapse | 6 | 3.5% | 0 | 1 |
Other Indications for HYALURONIDASE-OCSQ\OCRELIZUMAB
Multiple sclerosis (65)
Product used for unknown indication (41)
Relapsing-remitting multiple sclerosis (20)
Primary progressive multiple sclerosis (14)
Other Drugs Used for Relapsing multiple sclerosis
OCRELIZUMAB (6,883)
OFATUMUMAB (3,705)
FINGOLIMOD (851)
GLATIRAMER (375)
ALEMTUZUMAB (350)
SIPONIMOD (194)
INTERFERON BETA-1A (192)
NATALIZUMAB (140)
RITUXIMAB (136)
OZANIMOD (127)